NUST Institutional Repository

Studying the Role of Modified Aptamer-8 for Efficient Detection of Immunoglobin-G Antibodies.

Show simple item record

dc.contributor.author Azam, Tehmina
dc.date.accessioned 2024-03-07T07:31:49Z
dc.date.available 2024-03-07T07:31:49Z
dc.date.issued 2023-05
dc.identifier.other 00000328135
dc.identifier.uri http://10.250.8.41:8080/xmlui/handle/123456789/42475
dc.description.abstract Immunoglobulin G (IgG) plays a critical role in the diagnosis of multiple pathological conditions, including autoimmune hepatitis, hepatitis B virus (HBV), chickenpox, and MMR (Mumps, Measles, and Rubella). However, dependable, sensitive, and selective IgG detection remains a challenge. The recent outbreak of SARS-CoV-2 has highlighted the significance of IgG biosensing. Therefore, this study aims to develop a novel IgG biosensing platform with improved reliability, sensitivity, and selectivity. The proposed biosensing platform consists of Aptamer 8 as a biorecognition element and gold interdigitated electrodes (IDEs) modified with perfluoro decanethiol (PFDT) as its main constituents. The IDEs were immersed in the PFDT solution for the self-assembled monolayer (SAM) deposition process for 24 hours at room temperature (RT), and then dried in a glove box with a nitrogen atmosphere. Aptamer 8 was used to functionalize PFDT-IDEs, and several dilutions of IgG were incubated onto the biosensor for the detection studies. Contact angle, SEM, AFM, XRD, FTIR spectroscopy, and electrochemical studies were done for characterization and detection studies. The proposed biosensing platform showed a limit of detection (LOD) of 13 ug/ml. Characterization studies demonstrated the successful modification of PFDT on IDEs and the functionalization of Aptamer 8 on PFDT-IDEs. Electrochemical studies revealed a significant increase in the current response upon the incubation of IgG on the biosensor. The proposed IgG biosensing platform with Aptamer 8 and gold interdigitated electrodes modified with perfluoro decanethiol showed improved reliability, sensitivity, and selectivity. This biosensing platform has potential applications for high throughput systems and point-of-care detection of IgG and other biomolecules. Future studies should focus on optimizing the biosensor's performance and exploring its application in clinical settings. en_US
dc.description.sponsorship Dr. Usman Liaqat en_US
dc.publisher SCME en_US
dc.subject Studying , Modified Aptamer-8, Efficient Detection, Immunoglobin-G Antibodies en_US
dc.title Studying the Role of Modified Aptamer-8 for Efficient Detection of Immunoglobin-G Antibodies. en_US
dc.type Thesis en_US


Files in this item

This item appears in the following Collection(s)

  • MS [364]

Show simple item record

Search DSpace


Advanced Search

Browse

My Account